市場調查報告書

外科用敷料市場 - 成長,趨勢,預測

Surgical Dressing Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921248
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
外科用敷料市場 - 成長,趨勢,預測 Surgical Dressing Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 110 Pages
簡介

本報告提供外科用敷料的世界市場調查,提供市場概要,各類型,終端用戶,各地區的市場趨勢,市場規模的變化與預測,市場促進·阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 一次敷料
    • 二次敷料
    • 其他
  • 各適用
    • 潰瘍
    • 燒傷
    • 器官移植
    • 循環系統疾病
    • 糖尿病為基礎的手術
    • 其他
  • 各終端用戶
    • 醫院·診所
    • 門診病人手術中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Acelity LP Inc.
    • 3M
    • Coloplast
    • Molnlycke Health Care AB
    • Cardinal Health Inc.
    • ConvaTec Group Plc
    • Medtronic Plc
    • Smith & Nephew Plc
    • Medline Industries Inc.
    • Advancis Medical
    • Johnson and Johnson

第7章 市場機會及未來趨勢

目錄
Product Code: 67081

Market Overview

The market for surgical wounds is majorly driven by the rising number of surgeries across the globe. The innovations in technology and the rising preference of the general population for minimally invasive surgeries are contributing to the growing volume of surgical procedures across the globe.

According to the European Union Statistics, during the year 2016-2017, in Germany, hip replacement surgery was performed for 304 times per 100,000 individuals. In Austria and Finland, it was around 273 and 265 per 100,000, respectively. As per the OECD stats, in Canada, the number of surgeries performed were 378,448 during the year 2013 and it has been increased to 396,218 in the year 2017. In France, surgeries performed in the year 2014 were 773,308 and it raised to 863,837 by the year 2017. Similarly, Other European countries such as Spain, Italy, Netherlands, etc. have also witnessed a rise in the number of surgeries performed.

National Quality Forum has stated in its report that the number of surgical procedures in the United States is continuously increasing annually and since the last decade, the rate of surgeries performed in the ambulatory surgery centers has increased by 300 percent. As per the factsheet provided by the Centre for Diseases Control and Prevention (CDC), during the year 2014, around 14.2 million operative procedures were performed in the United States and around 157,500 surgical site infections (SSIs) were seen among these surgeries.

This rising number of surgeries is directly contributing to the growth of the market studied as wounds due to the surgery are also increasing. In addition, companies such as Coloplast and Smith and Nephew are into the market providing widely accepted products to deal with the surgical wounds which add strength to the market.

Scope of the Report

Surgical Dressing is a sterile pad or compresses which is applied to the wound after surgery to accelerate the wound healing and avoid further harm to the organ. The market is segmented by product, application, end-user, and geography.

Key Market Trends

Foam Dressing to Witness Healthy CAGR Over the Forecast Period

Foam dressing is an extremely absorbent dressing used for wound care. Foam dressings need less changing of dressings when compared to other types of dressings. Foam dressing works for heavily exuding wounds, like weeping ulcers, deep cavity wounds, wounds caused after debridement, etc.

These are generally made from semi-permeable polyurethane. They allow water vapor to enter but keep out contaminants and bacteria. In some cases, the outer layer of these dressings may be waterproof, depending upon the need. A​ variety of wound types, with at least a moderate amount of exudate, including abrasions, lacerations, pressure ulcers, incisions, infected wounds, and draining periosteal wounds, are expected to benefit from foam dressings. Foam dressings are usually prescribed for their biggest advantage: providing a moist and warm environment, which is ideal for healing. These dressings are majorly used for full or partial-thickness wounds, that have moderate or more drainage.

Furthermore, these dressings serve as a cushion to protect the affected area and also act as a barrier against bacteria during compression therapy. The ability of these dressings to be used as primary dressings or secondary dressings during accidents or other serious cases is expected to increase its adoption.

The United States to Dominate the Market

Major factors that are driving the market for surgical dressing in the United States are rapidly growing aging population, a high number of diabetic population, and the developed healthcare system which adapts to the novel innovations. The statistics show that around 30.3 million people in the United States were suffering from Diabetes in the year 2017 and subsequently, the number is increasing. The International Diabetes Federation has stated that in the whole North America region, the number of people suffering from Diabetes by the year 2045 would reach up to 62 million.

Added to that, companies such as Cardinal Health, Coloplast A/S, Integra Lifesciences, etc. are having a large portfolio of surgical dressing and these companies hold a healthy share in the United States. Hence, owing to the above-mentioned factors, the market studied is expected to be dominated by the United States.

Competitive Landscape

The market players are committed to developing innovative healing solutions for customers and patients across the care continuum, generating proven clinical outcomes. The companies are also showing continuous growth and are developing new and differentiated products and services, which address the evolving healthcare needs among patients, providers, and consumers.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Cases of Lifestyle Diseases and Increasing Number of Surgeries Across the Globe
    • 4.2.2 Growing Number of Ambulatory Surgical Centers
    • 4.2.3 Increasing Organ Transplant
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies
    • 4.3.2 Lack of Reimbursement and High Treatment Costs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Primary Dressing
      • 5.1.1.1 Film Dressing
      • 5.1.1.2 Hydrogel Dressing
      • 5.1.1.3 Hydrocolloid Dressing
      • 5.1.1.4 Foam Dressing
      • 5.1.1.5 Alginate Dressing
      • 5.1.1.6 Others
    • 5.1.2 Secondary Dressing
      • 5.1.2.1 Absorbents
      • 5.1.2.2 Bandages
      • 5.1.2.3 Adhesive Tapes
      • 5.1.2.4 Protectives
      • 5.1.2.5 Others
    • 5.1.3 Others
  • 5.2 By Application
    • 5.2.1 Ulcers
    • 5.2.2 Burns
    • 5.2.3 Organ Transplants
    • 5.2.4 Cardiovascular Disease
    • 5.2.5 Diabetes Based Surgeries
    • 5.2.6 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals/Clinics
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Acelity LP Inc.
    • 6.1.2 3M
    • 6.1.3 Coloplast
    • 6.1.4 Molnlycke Health Care AB
    • 6.1.5 Cardinal Health Inc.
    • 6.1.6 ConvaTec Group Plc
    • 6.1.7 Medtronic Plc
    • 6.1.8 Smith & Nephew Plc
    • 6.1.9 Medline Industries Inc.
    • 6.1.10 Advancis Medical
    • 6.1.11 Johnson and Johnson

7 MARKET OPPORTUNITIES AND FUTURE TRENDS